Author:
Getaneh Feven W.,Simhal Rishabh,Sholklapper Tamir,Melvin Emilie,Dorris Charles Scott,Chou Jiling,Richter Lee A.,Dieter Alexis
Publisher
Springer Science and Business Media LLC
Subject
Urology,Obstetrics and Gynecology
Reference41 articles.
1. Miotla P, Cartwright R, Futyma K, et al. Can Botox improve night-time overactive bladder symptoms in women? Neurourol Urodyn. 2017;36:648–52.
2. Amundsen CL, Richter HE, Menefee SA, et al. OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial. JAMA. 2016;316:1366–74.
3. Granese R, Adile G, Gugliotta G, Cucinella G, Saitta S, Adile B. Botox(®) for idiopathic overactive bladder: efficacy, duration and safety. Effectiveness of subsequent injection. Arch Gynecol Obstet. 2012;286:923–9.
4. Allergan. Botox (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use. Allergan Database Madison, NJ: Allergan USA; Updated 1 August 2022.
5. Visco AG, Brubaker L, Richter HE, et al. Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. N Engl J Med. 2012;367:1803–13.